July 29, 2011 -- Shanxi C&Y Pharmaceutical Investment Holdings has received regulatory approval to IPO on Shenzhen’s ChiNext exchange. Shanxi C&Y focuses on anti-infectives including new forms of antibiotics as well as other pharma products. The company, which will offer 33.8 million shares in the offering, plans to announce its IPO price on August 5. More details....
